RecruitingNot ApplicableNCT04461171
Enhanced Recovery After Surgery in Extremity Sarcoma
Sponsor
Joshua Lawrenz
Enrollment
120 participants
Start Date
Dec 14, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is evaluating a structured recovery program (Enhanced Recovery After Surgery, or ERAS) for patients who undergo surgery to remove a suspected sarcoma (a type of cancer that grows in bones, muscles, or soft tissue) from a limb. The program aims to improve recovery speed and reduce complications after surgery.
**You may be eligible if:**
- You are being treated at Vanderbilt University Medical Center
- You are over 17 years old
- You are having surgery to remove a suspected extremity (arm or leg) sarcoma
- You use opioid pain medications or do not — both groups are welcome
**You may NOT be eligible if:**
- You are being treated without surgery
- You do not speak English
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREEnhanced Recovery After Surgery
Undergo an enhanced recovery after surgery program
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04461171
Related Trials
DESTINY-PANTUMOUR04
NCT0712400017 locations
A Study of CRD3874-SI in People With Solid Tumors
NCT060216267 locations
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT065031461 location
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
NCT023907521 location
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT011093945 locations